COST-EFFECTIVENESS OF BREXUCABTAGENE AUTOLEUCEL FOR THE TREATMENT OF RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN PATIENTS AGED 26 YEARS OR OLDER IN GREECE

被引：0
|
作者：
Vellopoulou, K. [1 ]
Tsirigotis, P. [2 ]
Chondropoulos, S. [2 ]
Konstantellos, I [2 ]
Qeodurasoy, N. [3 ]
Spousta, T. [4 ]
Van Hees, F. [4 ]
Smith, N. [4 ]
Doble, B. [5 ]
机构：
[1] Econcare LP, Athens, Greece
[2] Attikon Univ, Gen Hosp, Athens, Greece
[3] Gilead Sci Hellas, Palaio Faliro, Greece
[4] Maple Hlth Grp LLC, New York, NY USA
[5] Kite A Gilead Co, Santa Monica, CA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE265
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [21] Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
    Shah, Bijal D.
    Cassaday, Ryan D.
    Park, Jae H.
    Houot, Roch
    Oluwole, Olalekan O.
    Logan, Aaron C.
    Boissel, Nicolas
    Leguay, Thibaut
    Bishop, Michael R.
    Topp, Max S.
    Tzachanis, Dimitrios
    O'Dwyer, Kristen M.
    Arellano, Martha L.
    Lin, Yi
    Baer, Maria R.
    Schiller, Gary J.
    Subklewe, Marion
    Abedi, Mehrdad
    Minnema, Monique C.
    Wierda, William G.
    DeAngelo, Daniel J.
    Stiff, Patrick J.
    Jeyakumar, Deepa
    Mao, Daqin
    Adhikary, Sabina
    Zhou, Lang
    Schuberth, Petra C.
    Damico Khalid, Rita
    Ghobadia, Armin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
  • [22] Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia in Japan
    Wakase, Shiho
    Teshima, Takanori
    Zhang, Jie
    Ma, Qiufei
    Watanabe, Yoko
    Yang, Hongbo
    Qi, Cynthia Z.
    Chai, Xinglei
    Xie, Yanwen
    Wu, Eric Q.
    Igarashi, Ataru
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (03): : 241.e1 - 241.e11
  • [23] Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States
    Shah, Bijal D.
    Smith, Nathaniel J.
    Feng, Chaoling
    Jeyakumar, Sushanth
    Castaigne, Jean-Gabriel
    Faghmous, Imi
    Masouleh, Behzad Kharabi
    Malone, Daniel C.
    Bishop, Michael R.
    ADVANCES IN THERAPY, 2022, 39 (08) : 3678 - 3695
  • [24] Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States
    Bijal D. Shah
    Nathaniel J. Smith
    Chaoling Feng
    Sushanth Jeyakumar
    Jean-Gabriel Castaigne
    Imi Faghmous
    Behzad Kharabi Masouleh
    Daniel C. Malone
    Michael R. Bishop
    Advances in Therapy, 2022, 39 : 3678 - 3695
  • [25] Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
    Sarkar, Reith R.
    Gloude, Nicholas J.
    Schiff, Deborah
    Murphy, James D.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (07): : 719 - 726
  • [26] COST-EFFECTIVENESS OF THE BREXU-CEL IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA AND B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A SYSTEMATIC REVIEW
    Khatiwada, A.
    Kamel, A.
    Ngorsuraches, S.
    VALUE IN HEALTH, 2024, 27 (06) : S80 - S80
  • [27] Cost-Effectiveness Analysis of CTL019 for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia in the United States
    Hao, Yanni
    Eldjerou, Lamis K.
    Yang, Hongbo
    Qi, Cynthia
    Globe, Denise
    BLOOD, 2017, 130
  • [28] Cost-Effectiveness Analysis of Tisagenlecleucel in the Treatment of Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia in Children and Young Adults in Spain
    Santasusana, Josep Maria Ribera
    de Andres Saldana, Alejandra
    Garcia-Munoz, Nuria
    Gostkorzewicz, Joana
    Martinez Llinas, Diana
    Diaz de Heredia, Cristina
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 253 - 264
  • [29] Cost-effectiveness studies of brexu-cel for relapsed/refractory B-cell acute lymphoblastic leukemia and mantle cell lymphoma: a systematic review
    Khatiwada, Asmita Priyadarshini
    Kamel, Ahmed Mostafa Ahmed
    Chaiyakunapruk, Nathorn
    Ngorsuraches, Surachat
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2025, 25 (03) : 323 - 335
  • [30] Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
    Enrico Maffini
    Francesco Saraceni
    Francesco Lanza
    Clinical Hematology International, 2019, 1 (2) : 85 - 93
12345